Related Experiment Video
Updated: Sep 13, 2025

11:01
Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
Published on: August 24, 2021
2.9K
Macropinocytosis: Both a Target and a Tool for Cancer Therapy
Manhan Zhao1, Liming Zhou1, Yifei Zhai1
1School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, China.
Biomolecules
|July 29, 2025
Summary
Cancer cells exploit macropinocytosis for nutrients and survival. This review explores targeting macropinocytosis and using it for drug delivery in novel cancer therapies.
Area of Science:
- Cell Biology
- Cancer Research
- Drug Delivery
Background:
- Macropinocytosis is a non-selective cellular process for bulk fluid uptake.
- Cancer cells hijack macropinocytosis for nutrients, aiding proliferation and survival.
- This process is a potential target for cancer therapy and a tool for drug delivery.
Purpose of the Study:
- To review therapeutic strategies targeting macropinocytosis in cancer.
- To explore macropinocytosis as a tool for anti-cancer drug delivery.
- To highlight advancements in macropinocytosis-based cancer treatments.
Main Methods:
- Systematic review of cancer therapeutic strategies.
- Analysis of macropinocytosis inhibitors and metabolic modulators.
- Evaluation of methuosis inducers and drug delivery systems (nanoparticles, viral vectors, EVs, conjugates).
Main Results:
- Macropinocytosis inhibitors and metabolic modulators show therapeutic potential.
- Methuosis inducers offer a novel cell death strategy.
- Various platforms effectively utilize macropinocytosis for targeted drug delivery.
Conclusions:
- Targeting macropinocytosis offers a promising avenue for cancer therapy.
- Macropinocytosis-dependent drug delivery systems present innovative treatment strategies.
- Further development in these areas could revolutionize cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Pinocytosis
3.4K
Cells use energy-requiring bulk transport mechanisms to transfer large particles or large numbers of small particles into or out of the cell. The cells envelop the particles in spherical membranes called vesicles or vacuoles. Vesicles that transport material into the cell are built from the cell membrane. These vesicles encapsulate external molecules and transport them into the cell in a process called endocytosis.
Pinocytosis ("cellular drinking") is one of three main types of...
Pinocytosis ("cellular drinking") is one of three main types of...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662

